ARENA PHARMACEUTICALS INC - 25 Jan 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc.

Role
Former 10% Owner
Signature
Arena Pharmaceuticals, Inc., By:/s/ Susan Grant, Assistant Secretary
Issuer symbol
N/A
Transactions as of
25 Jan 2024
Net transactions value
-$96,479,595
Form type
4
Filing time
29 Jan 2024, 16:37:44 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LBPH Voting Common Stock Sale $96,479,595 -3,978,540 -100% $24.25* 0 25 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

ARENA PHARMACEUTICALS INC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The per share price is reported before fees.